Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity

Archives of Biochemistry and Biophysics
J WanYoshihiko Funae

Abstract

We cloned four cDNAs belonging to the CYP2D subfamily to express these enzymes in yeast cells and to compare their catalytic activities simultaneously. Three are believed to be alleles of CYP2D1, 2D2, and 2D3, respectively, based on high nucleotide sequence similarity, while CYP2D4 had both sequences of CYP2D4 and CYP2D18. Expression plasmids carrying CYP2D cDNAs were transformed into Saccharomyces cerevisiae. Typical P450 CO-difference spectra with absorbance maximum at 448 nm were recorded with microsomal preparations from the yeast cells expressing the four CYP2D forms. A catalytic study of these CYP2D forms was done with debrisoquine, bufuralol, and lidocaine. CYP2D2 had the highest debrisoquine 4-hydroxylation (2.2 nmol/min/nmol P450) activity, similar to that (2.2 nmol/min/nmol) of human CYP2D6 expressed in yeast cells. CYP2D3 had high lidocaine N-deethylation (43 nmol/min/nmol P450) activity, and both CYP2D3 and 2D2 exhibited high lidocaine 3-hydroxylation (2.4 and 1.6 nmol/min/nmol P450, respectively) activity. Bufuralol 1'-hydroxylation catalytic capabilities were comparable among the four isoforms. The activity of CYP2D1 was relatively low toward the three substrates (debrisoquine, 0.091; bufuralol, 1.5; lidocaine 3-h...Continue Reading

Citations

Mar 23, 2002·The Pharmacogenomics Journal·T HanataniJ Azuma
Apr 2, 2005·Biological & Pharmaceutical Bulletin·Takashi IsobeShizuo Narimatsu
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Aug 20, 2009·Expert Opinion on Drug Metabolism & Toxicology·Noriaki Sakai, Mayumi Ishizuka
Mar 16, 2000·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M ChibaJ H Lin
Apr 25, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N HaniokaS Narimatsu
Aug 3, 2000·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S MiksysR F Tyndale
Jul 4, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Marta KotWładysława A Daniel
Jan 1, 2014·European Journal of Pharmacology·Xiaoshuang WangJiang Yue
Nov 4, 2004·Aquatic Toxicology·Woon-Gye ChungDonald R Buhler
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Yoshihiko FunaeToyoko Hiroi
Nov 6, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Barent N DuBoisReza Mehvar
Feb 13, 2010·Basic & Clinical Pharmacology & Toxicology·Nobumitsu HaniokaShizuo Narimatsu
May 23, 2002·The Journal of Pharmacology and Experimental Therapeutics·Camille P GranvilFrank J Gonzalez
Oct 18, 2003·Endocrinology·Wataru KishimotoYoshihiko Funae
Dec 24, 2002·The Journal of Pharmacy and Pharmacology·Władysława A DanielJ Wójcikowski
Aug 9, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Toyoko HiroiYoshihiko Funae
Mar 28, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Marcella MartignoniRuben de Kanter
Aug 6, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Noriaki SakaiShoichi Fujita
Aug 9, 2013·Biochemical Pharmacology·Anna Sadakierska-ChudyWładysława A Daniel
Jun 9, 2001·Biochemical and Biophysical Research Communications·S ImaokaY Funae
Jan 27, 1999·Chemico-biological Interactions·N HaniokaK Ogawa
Sep 18, 2002·Biochemical Pharmacology·Hiroyuki HichiyaShizuo Narimatsu
Oct 12, 2004·Biochemical and Biophysical Research Communications·Shizuo NarimatsuShigeo Yamamoto
Oct 13, 2009·European Journal of Pharmacology·Ewa BromekWładysława A Daniel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.